These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16198160)

  • 1. Features and potentials of ATP-site directed CK2 inhibitors.
    Sarno S; Salvi M; Battistutta R; Zanotti G; Pinna LA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):263-70. PubMed ID: 16198160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP site-directed inhibitors of protein kinase CK2: an update.
    Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
    Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.
    Meggio F; Pagano MA; Moro S; Zagotto G; Ruzzene M; Sarno S; Cozza G; Bain J; Elliott M; Deana AD; Brunati AM; Pinna LA
    Biochemistry; 2004 Oct; 43(40):12931-6. PubMed ID: 15461466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA
    Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Bdzhola VG; Sapelkin VM; Zien P; Yarmoluk SM
    J Med Chem; 2006 Nov; 49(22):6443-50. PubMed ID: 17064064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
    Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
    Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
    Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
    Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase CK2 as a druggable target.
    Sarno S; Pinna LA
    Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural insight into CK2 inhibition.
    Mazzorana M; Pinna LA; Battistutta R
    Mol Cell Biochem; 2008 Sep; 316(1-2):57-62. PubMed ID: 18626746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R; Cochet C
    Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach.
    Retegan M; Milet A; Jamet H
    J Chem Inf Model; 2009 Apr; 49(4):963-71. PubMed ID: 19354274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules.
    Battistutta R; Mazzorana M; Cendron L; Bortolato A; Sarno S; Kazimierczuk Z; Zanotti G; Moro S; Pinna LA
    Chembiochem; 2007 Oct; 8(15):1804-9. PubMed ID: 17768728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selectivity of inhibitors of protein kinase CK2: an update.
    Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
    Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
    López-Ramos M; Prudent R; Moucadel V; Sautel CF; Barette C; Lafanechère L; Mouawad L; Grierson D; Schmidt F; Florent JC; Filippakopoulos P; Bullock AN; Knapp S; Reiser JB; Cochet C
    FASEB J; 2010 Sep; 24(9):3171-85. PubMed ID: 20400536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.